BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21859040)

  • 1. Characteristics of an OSLD in the diagnostic energy range.
    Al-Senan RM; Hatab MR
    Med Phys; 2011 Jul; 38(7):4396-405. PubMed ID: 21859040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an optically stimulated dosimeter for dentomaxillofacial dosimetry.
    Valiyaparambil JV; Mallya SM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Dec; 112(6):793-7. PubMed ID: 21983291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the nanoDot OSLD dosimeter in CT.
    Scarboro SB; Cody D; Alvarez P; Followill D; Court L; Stingo FC; Zhang D; McNitt-Gray M; Kry SF
    Med Phys; 2015 Apr; 42(4):1797-807. PubMed ID: 25832070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angular dependence of dose sensitivity of nanoDot optically stimulated luminescent dosimeters in different radiation geometries.
    Jursinic PA
    Med Phys; 2015 Oct; 42(10):5633-41. PubMed ID: 26429237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of optically stimulated luminescence dosimeters in the spread-out Bragg peak region of clinical proton beams.
    Kerns JR; Kry SF; Sahoo N
    Med Phys; 2012 Apr; 39(4):1854-63. PubMed ID: 22482607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in optically stimulated luminescent dosimeter (OSLD) dosimetric characteristics with accumulated dose.
    Jursinic PA
    Med Phys; 2010 Jan; 37(1):132-40. PubMed ID: 20175474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the optically stimulated luminescence (OSL) technique for mouse dosimetry in micro-CT imaging.
    Vrigneaud JM; Courteau A; Ranouil J; Morgand L; Raguin O; Walker P; Oudot A; Collin B; Brunotte F
    Med Phys; 2013 Dec; 40(12):122102. PubMed ID: 24320529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical note: High-dose and ultra-high dose rate (UHDR) evaluation of Al
    Liu K; Velasquez B; Schüler E
    Med Phys; 2024 Mar; 51(3):2311-2319. PubMed ID: 37991111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of nanoDot optically stimulated luminescence detectors and high-sensitivity MCP-N thermoluminescent detectors in the 40-300 kVp energy range.
    Poirier Y; Kuznetsova S; Villarreal-Barajas JE
    Med Phys; 2018 Jan; 45(1):402-413. PubMed ID: 29164632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of optically stimulated luminescent dosimeters, OSLDs, for clinical dosimetric measurements.
    Jursinic PA
    Med Phys; 2007 Dec; 34(12):4594-604. PubMed ID: 18196786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angular dependence of the nanoDot OSL dosimeter.
    Kerns JR; Kry SF; Sahoo N; Followill DS; Ibbott GS
    Med Phys; 2011 Jul; 38(7):3955-62. PubMed ID: 21858992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optically stimulated luminescent dosimeters stable response to dose after repeated bleaching.
    Jursinic PA
    Med Phys; 2020 Jul; 47(7):3191-3203. PubMed ID: 32297332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remote auditing of radiotherapy facilities using optically stimulated luminescence dosimeters.
    Lye J; Dunn L; Kenny J; Lehmann J; Kron T; Oliver C; Butler D; Alves A; Johnston P; Franich R; Williams I
    Med Phys; 2014 Mar; 41(3):032102. PubMed ID: 24593737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo dosimetry with optically stimulated luminescent dosimeters, OSLDs, compared to diodes; the effects of buildup cap thickness and fabrication material.
    Jursinic PA; Yahnke CJ
    Med Phys; 2011 Oct; 38(10):5432-40. PubMed ID: 21992362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative dose evaluations between XVI and OBI cone beam CT systems using Gafchromic XRQA2 film and nanoDot optical stimulated luminescence dosimeters.
    Giaddui T; Cui Y; Galvin J; Yu Y; Xiao Y
    Med Phys; 2013 Jun; 40(6):062102. PubMed ID: 23718600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SU-E-T-169: Initial Investigation into the Use of Optically Stimulated Luminescent Dosimeters (OSLDs) for In-Vivo Dosimetry of TBI Patients.
    Paloor S; Aland T; Mathew J; Al-Hammadi N; Hammoud R
    Med Phys; 2012 Jun; 39(6Part12):3742. PubMed ID: 28517806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo measurements for high dose rate brachytherapy with optically stimulated luminescent dosimeters.
    Sharma R; Jursinic PA
    Med Phys; 2013 Jul; 40(7):071730. PubMed ID: 23822434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of different bleaching wavelengths on the sensitivity of Al(2)O(3):C optically stimulated luminescence detectors (OSLDs) exposed to 6 MV photon beams.
    Omotayo AA; Cygler JE; Sawakuchi GO
    Med Phys; 2012 Sep; 39(9):5457-68. PubMed ID: 22957613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a commercially-available, optically-stimulated luminescent dosimetry system for use in computed tomography.
    Lavoie L; Ghita M; Brateman L; Arreola M
    Health Phys; 2011 Sep; 101(3):299-310. PubMed ID: 21799346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of multislice computed tomography dose index (CTDI) using optically stimulated luminescence technology.
    Ruan C; Yukihara EG; Clouse WJ; Gasparian PB; Ahmad S
    Med Phys; 2010 Jul; 37(7):3560-8. PubMed ID: 20831063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.